17th May 2022 | Pharma Updates
US FDA defined quality issues at Sun Pharma's Gujaratfacility
US Food and Drug Administration has identified production-related quality control and procedural faults, as well as inadequate equipment and laboratory standards, at Sun Pharma’s Gujarat facility.
Honasa Consumer acquired majority stake in the Dr. Sheth's skincare brand
Honasa Consumer, the parent company of Mamaearth and The Derma Co., announced the acquisition of skincare brand Dr. Sheth’s. HCPL now owns a majority stake in Dr Sheth’s for Rs 28 crore.
Multiples and other investors contribute Rs 685 crore to BDR Pharma
BDR Pharma, a pharmaceutical company, has raised Rs.685 crore from a group of investors led by private equity firm Multiples and invested Rs.685 crore in BDR Pharma for 9.3 percent stake.
Pfizer documents do not reveal the risks of the Covid-19 vaccine
Health authorities, including the World Health Organization, have monitored the shot’s safety, and many independent scientists believe that the data shows that the benefits outweigh the risks.
With the advent of new technologies, India is moving toward universal healthcare: Gaurav Dubey, LivLong
The healthcare market is currently very unorganised, and how it evolves in the future will pave the way for the introduction of new trends and technologies in this sector.
Sanofi ordered to compensate a French family for the side effects of an epilepsy drug
A French court has ordered Sanofi to pay more than 400,000 euros in damages to a family whose child was diagnosed with a form of autism caused by the epilepsy drug valproate, marketed in France as Depakine.
EU informed Valneva to cancelthe COVID vaccine deal
Valneva stated that the European Commission (EC) informed the company of its intention to terminate an advance purchase agreement for its COVID vaccine.
You must be logged in to post a comment.